Bromotryptamine and Bromotyramine Derivatives from the Tropical Southwestern Pacific Sponge Narrabeena nigra
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10347/21311
Files in this item
Metadata
Title: | Bromotryptamine and Bromotyramine Derivatives from the Tropical Southwestern Pacific Sponge Narrabeena nigra |
Author: | Miguel Gordo, María Gegunde Mosquera, Sandra Calabro, Kevin Jennings, Laurence K. Alfonso Rancaño, María Amparo Genta-Jouve, Grégory Vacelet, Jean Botana López, Luis Miguel Thomas, Olivier P. |
Affiliation: | Universidade de Santiago de Compostela. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica |
Subject: | Futuna | Porifera | Narrabeena | Coral reefs | Aromatic alkaloids | Bromotryptamine | Bromotyramine | Neuroprotective agents | |
Date of Issue: | 2019 |
Publisher: | MDPI |
Citation: | Miguel-Gordo, M.; Gegunde, S.; Calabro, K.; Jennings, L.K.; Alfonso, A.; Genta-Jouve, G.; Vacelet, J.; Botana, L.M.; Thomas, O.P. Bromotryptamine and Bromotyramine Derivatives from the Tropical Southwestern Pacific Sponge Narrabeena nigra. Mar. Drugs 2019, 17, 319 |
Abstract: | So far, the Futuna Islands located in the Central Indo-Pacific Ocean have not been inventoried for their diversity in marine sponges and associated chemical diversity. As part of the Tara Pacific expedition, the first chemical investigation of the sponge Narrabeena nigra collected around the Futuna Islands yielded 18 brominated alkaloids: seven new bromotryptamine derivatives 1–7 and one new bromotyramine derivative 8 together with 10 known metabolites of both families 9–18. Their structures were deduced from extensive analyses of nuclear magnetic resonance (NMR) and high-resolution mass spectrometry (HRMS) data. In silico metabolite anticipation using the online tool MetWork revealed the presence of a key and minor biosynthetic intermediates. These 18 compounds showed almost no cytotoxic effect up to 10 µM on human neuroblastoma SH-SY5Y and microglia BV2 cells, and some of them exhibited an interesting neuroprotective activity by reducing oxidative damage |
Publisher version: | https://doi.org/10.3390/md17060319 |
URI: | http://hdl.handle.net/10347/21311 |
DOI: | 10.3390/md17060319 |
E-ISSN: | 1660-3397 |
Rights: | © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/) |
Collections
-
- FTF-Artigos [242]
Except where otherwise noted, this item's license is described as © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)